Startupsby GlyphWhy it ranks
How the rank works- team of 17Team size · YC's directory+6.5
- went through YCProgram · this site+4
A sum of public facts, not a judgement and not investment advice.
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW21 | |
| AI | Active | YCS19 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Active | YCW23 | |
| Other | Active | YCW22 | |
| Other | Active | YCS19 | |
| Pardes BiosciencesShared: therapeutics, biotech, drugYC S20PublicOther | Other | Public | YCS20 |
| AI | Active | YCS23 |
Also from W20 in AI
All of W20About Algen Biotechnologies
Algen is using CRISPR to uncover disease-driving RNA messages to find treatments for cancer, inflammation and diseases with high unmet needs. We are harnessing the power of CRISPR gene-modulation and frontier AI to find drugs that modulate RNA messages at single-cell resolution. Algen's founders are bioengineer from Jennifer Doudna Lab and biotech commercialization expert, teamed up with experienced pharmaceutical executives.
- YC batch
- W20 · Winter 2020
- Status, per YC
- Active
- Category
- AI
- Team size
- 17
- Location
- San Francisco, CA, USA
- Checked
- 7h ago
YC tags: CRISPR, Biotech, Therapeutics, Drug discovery, AI
Changes seen
Team went from 15 to 17 people.
Algen Biotechnologies: questions
Which YC batch was Algen Biotechnologies in?
Algen Biotechnologies was in Y Combinator's Winter 2020 batch (W20).
Is Algen Biotechnologies still active?
Y Combinator lists Algen Biotechnologies as active.
Where is Algen Biotechnologies based?
Algen Biotechnologies lists San Francisco, CA, USA as its location on YC's directory.